La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale?

Translated title of the contribution: Can intestinal transplantation constitute treatment for intestinal failure?

O. Goulet, J. L. Michel, N. Brousse, Dominique M. Jan, C. Ricour, Y. Revillon

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based parental nutrition. Intestinal transplantation is now possible and in some conditions, constitutes the logical treatment option. Since 1985, more than 300 small- bowel grafts have been performed, involving the isolated small bowel with or without the colon (45 %), the liver + small bowel (40 %) or several organs (15 %). 2/3 of recipients were under 20 years of age, and indications were short-bowel syndrome (64 %), severe intractable diarrhea (13 %), abdominal cancer (13 %), or chronic intestinal pseudo-obstruction syndrome (8 %). 51 % of patients survived > 2 years after the graft. Patient and graft survival depends on the type of immunosuppression, i.e. Ciclosporine or FK 506. The results must be interpreted carefully as they represent the first experience in numerous centers using different immunosuppressive protocols, without any randomization. The results from the largest of these centers more closely reflect the current situation and may exceed a 70 % 2-year survival rate. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or persistently dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication for transplantation must be carefully weighed up in terms of the iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be undertaken. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is only indicated in case of life-threatening progressive cirrhogenic liver disease.

Original languageFrench
Pages (from-to)412-421
Number of pages10
JournalAnnales de Chirurgie
Volume53
Issue number5
StatePublished - 1999
Externally publishedYes

Fingerprint

Treatment Failure
Parenteral Nutrition
Transplantation
Transplants
Liver
Home Parenteral Nutrition
Intestinal Pseudo-Obstruction
Short Bowel Syndrome
Tacrolimus
Graft Survival
Immunosuppressive Agents
Random Allocation
Weaning
Nutritional Status
Immunosuppression
Blood Vessels
Liver Diseases
Diarrhea
Colon
Survival Rate

Keywords

  • Acute graft rejection
  • Intestinal failure
  • Intestinal transplantation
  • Parenteral nutrition
  • Short bowel syndrome

ASJC Scopus subject areas

  • Surgery

Cite this

Goulet, O., Michel, J. L., Brousse, N., Jan, D. M., Ricour, C., & Revillon, Y. (1999). La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale? Annales de Chirurgie, 53(5), 412-421.

La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale? / Goulet, O.; Michel, J. L.; Brousse, N.; Jan, Dominique M.; Ricour, C.; Revillon, Y.

In: Annales de Chirurgie, Vol. 53, No. 5, 1999, p. 412-421.

Research output: Contribution to journalArticle

Goulet, O, Michel, JL, Brousse, N, Jan, DM, Ricour, C & Revillon, Y 1999, 'La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale?', Annales de Chirurgie, vol. 53, no. 5, pp. 412-421.
Goulet, O. ; Michel, J. L. ; Brousse, N. ; Jan, Dominique M. ; Ricour, C. ; Revillon, Y. / La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale?. In: Annales de Chirurgie. 1999 ; Vol. 53, No. 5. pp. 412-421.
@article{61d257edf0024acbab7d2342180d45b2,
title = "La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale?",
abstract = "The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based parental nutrition. Intestinal transplantation is now possible and in some conditions, constitutes the logical treatment option. Since 1985, more than 300 small- bowel grafts have been performed, involving the isolated small bowel with or without the colon (45 {\%}), the liver + small bowel (40 {\%}) or several organs (15 {\%}). 2/3 of recipients were under 20 years of age, and indications were short-bowel syndrome (64 {\%}), severe intractable diarrhea (13 {\%}), abdominal cancer (13 {\%}), or chronic intestinal pseudo-obstruction syndrome (8 {\%}). 51 {\%} of patients survived > 2 years after the graft. Patient and graft survival depends on the type of immunosuppression, i.e. Ciclosporine or FK 506. The results must be interpreted carefully as they represent the first experience in numerous centers using different immunosuppressive protocols, without any randomization. The results from the largest of these centers more closely reflect the current situation and may exceed a 70 {\%} 2-year survival rate. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or persistently dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication for transplantation must be carefully weighed up in terms of the iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be undertaken. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is only indicated in case of life-threatening progressive cirrhogenic liver disease.",
keywords = "Acute graft rejection, Intestinal failure, Intestinal transplantation, Parenteral nutrition, Short bowel syndrome",
author = "O. Goulet and Michel, {J. L.} and N. Brousse and Jan, {Dominique M.} and C. Ricour and Y. Revillon",
year = "1999",
language = "French",
volume = "53",
pages = "412--421",
journal = "Journal de Chirurgie Viscerale",
issn = "1878-786X",
publisher = "Elsevier Masson",
number = "5",

}

TY - JOUR

T1 - La transplantation intestinale peut-elle etre la therapeutique de l'insuffisance intestinale?

AU - Goulet, O.

AU - Michel, J. L.

AU - Brousse, N.

AU - Jan, Dominique M.

AU - Ricour, C.

AU - Revillon, Y.

PY - 1999

Y1 - 1999

N2 - The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based parental nutrition. Intestinal transplantation is now possible and in some conditions, constitutes the logical treatment option. Since 1985, more than 300 small- bowel grafts have been performed, involving the isolated small bowel with or without the colon (45 %), the liver + small bowel (40 %) or several organs (15 %). 2/3 of recipients were under 20 years of age, and indications were short-bowel syndrome (64 %), severe intractable diarrhea (13 %), abdominal cancer (13 %), or chronic intestinal pseudo-obstruction syndrome (8 %). 51 % of patients survived > 2 years after the graft. Patient and graft survival depends on the type of immunosuppression, i.e. Ciclosporine or FK 506. The results must be interpreted carefully as they represent the first experience in numerous centers using different immunosuppressive protocols, without any randomization. The results from the largest of these centers more closely reflect the current situation and may exceed a 70 % 2-year survival rate. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or persistently dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication for transplantation must be carefully weighed up in terms of the iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be undertaken. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is only indicated in case of life-threatening progressive cirrhogenic liver disease.

AB - The management of patients with intestinal failure has benefited from progress in parenteral nutrition (PN), especially home-based parental nutrition. Intestinal transplantation is now possible and in some conditions, constitutes the logical treatment option. Since 1985, more than 300 small- bowel grafts have been performed, involving the isolated small bowel with or without the colon (45 %), the liver + small bowel (40 %) or several organs (15 %). 2/3 of recipients were under 20 years of age, and indications were short-bowel syndrome (64 %), severe intractable diarrhea (13 %), abdominal cancer (13 %), or chronic intestinal pseudo-obstruction syndrome (8 %). 51 % of patients survived > 2 years after the graft. Patient and graft survival depends on the type of immunosuppression, i.e. Ciclosporine or FK 506. The results must be interpreted carefully as they represent the first experience in numerous centers using different immunosuppressive protocols, without any randomization. The results from the largest of these centers more closely reflect the current situation and may exceed a 70 % 2-year survival rate. Functional grafts lead to gastrointestinal autonomy (weaning of PN) while maintaining satisfactory nutritional status and normal growth in childhood. Intestinal transplantation is theoretically indicated for all patients permanently or persistently dependent on PN. However, as PN is generally well tolerated, even for long periods, each indication for transplantation must be carefully weighed up in terms of the iatrogenic risk and quality of life. When PN has reached its limits, especially those associated with vascular, infectious, hepatic or metabolic complications, intestinal transplantation must be undertaken. Transplantation of the small bowel alone remains the first option, as combined liver-small bowel grafting is only indicated in case of life-threatening progressive cirrhogenic liver disease.

KW - Acute graft rejection

KW - Intestinal failure

KW - Intestinal transplantation

KW - Parenteral nutrition

KW - Short bowel syndrome

UR - http://www.scopus.com/inward/record.url?scp=0033013302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033013302&partnerID=8YFLogxK

M3 - Article

C2 - 10389331

AN - SCOPUS:0033013302

VL - 53

SP - 412

EP - 421

JO - Journal de Chirurgie Viscerale

JF - Journal de Chirurgie Viscerale

SN - 1878-786X

IS - 5

ER -